Lisata Therapeutics to Present at BIO CEO & Investor Conference

February 20, 2024

https://www.globenewswire.com/news-release/2024/02/20/2831757/18623/en/Lisata-Therapeutics-to-Present-at-BIO-CEO-Investor-Conference.html

BASKING RIDGE, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq:LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, Ph.D., President and Chief Executive Officer of Lisata, will present at the BIO CEO & Investor Conference being held on February 26-27, 2024 at the New York Marriott Marquis in New York City.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.